The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.

[1]  Mahmi Fujimori,et al.  Melatonin Action on the Activity of Phagocytes from the Colostrum of Obese Women , 2019, Medicina.

[2]  T. Pawlik,et al.  Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients , 2018, Journal of cachexia, sarcopenia and muscle.

[3]  E. Levy,et al.  Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress. , 2017, Antioxidants & redox signaling.

[4]  E. Heggen,et al.  Characteristics of Metabolic Syndrome in Morbidly Obese Subjects. , 2016, Metabolic syndrome and related disorders.

[5]  H. Robberecht,et al.  Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance. , 2016, Metabolic syndrome and related disorders.

[6]  M. Fernández,et al.  A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome. , 2015, Metabolic syndrome and related disorders.

[7]  C. Apovian,et al.  Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  B. Adams-Huet,et al.  Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. , 2014, Atherosclerosis.

[9]  G. Bray,et al.  American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[11]  G. Plourde,et al.  Current issues in the identification and treatment of metabolically healthy but obese individuals. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  Janusz Wnek,et al.  2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.

[13]  S. Devaraj,et al.  Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.

[14]  B. Schultes,et al.  Waist Circumference and Related Anthropometric Indices Are Associated with Metabolic Traits in Severely Obese Subjects , 2014, Obesity Surgery.

[15]  B. Klop,et al.  Dyslipidemia in Obesity: Mechanisms and Potential Targets , 2013, Nutrients.

[16]  B. Adams-Huet,et al.  Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  S. Devaraj,et al.  Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome , 2012, Diabetes Care.

[18]  S. Devaraj,et al.  Adipose tissue dysregulation in patients with metabolic syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[19]  J. Faintuch,et al.  Inflammation and Biochemical Features of Bariatric Candidates: Does Gender Matter? , 2011, Obesity surgery.

[20]  F. Tinahones,et al.  Obesity and Insulin Resistance-Related Changes in the Expression of Lipogenic and Lipolytic Genes in Morbidly Obese Subjects , 2010, Obesity surgery.

[21]  S. Msika,et al.  Traditional Anthropometric Parameters Still Predict Metabolic Disorders in Women With Severe Obesity , 2010, Obesity.

[22]  G. Marchesini,et al.  Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity , 2010, Obesity surgery.

[23]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[24]  U. Singh,et al.  Human C-reactive protein and the metabolic syndrome , 2009, Current opinion in lipidology.

[25]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.